About the Authors
- Danielle H. Bodicoat
-
* E-mail: dhm6@le.ac.uk
Affiliation University of Leicester, Diabetes Research Centre, Leicester, Leicestershire, United Kingdom
- Laura J. Gray
-
Affiliation University of Leicester, Department of Health Sciences, Leicester, Leicestershire, United Kingdom
- Joseph Henson
-
Affiliation University of Leicester, Diabetes Research Centre, Leicester, Leicestershire, United Kingdom
- David Webb
-
Affiliation University of Leicester, Diabetes Research Centre, Leicester, Leicestershire, United Kingdom
- Arvind Guru
-
Affiliation Postgraduate Institute of Medical Education and Research, Chandigarh, Punjab, India
- Anoop Misra
-
Affiliation Fortis Hospitals, Department of Diabetes and Metabolic Diseases, New Delhi, Delhi, India
- Rajeev Gupta
-
Affiliation Fortis Escorts Hospital, Department of Internal Medicine, Jaipur, Rajasthan, India
- Naval Vikram
-
Affiliation All India Institute of Medical Sciences, Department of Medicine, New Delhi, Delhi, India
- Naveed Sattar
-
Affiliation University of Glasgow, Institute of Cardiovascular and Medical Sciences, Glasgow, United Kingdom
- Melanie J. Davies
-
Affiliation University of Leicester, Diabetes Research Centre, Leicester, Leicestershire, United Kingdom
- Kamlesh Khunti
-
Affiliation University of Leicester, Diabetes Research Centre, Leicester, Leicestershire, United Kingdom
Competing Interests
DHB, KK and NS have support from the National Institute for Health And Care Excellence (NICE) for the submitted work and were advisors to the NICE group “Assessing body mass index and waist circumference thresholds for intervening to prevent ill health and premature death among adults from black, Asian and other minority ethnicity groups in the UK.” MJD has received funds for research, honoraria for speaking at meetings and has served on Advisory Boards for Lilly, Sanofi Aventis, MSD, Novo Nordisk, BMS, BI and Roche. KK has received funds for research, honoraria for speaking at meetings and/or served on Advisory Boards for Astra Zeneca, Lilly, Novartis, Pfizer, Servier, Sanofi Aventis, MSD and Novo Nordisk. KK (Chair) and MJD are members of the National Institute for Health and Clinical Excellence Public Health Guidance on prevention of Type 2 diabetes among people with prediabetes. MJD and KK are advisors to the UK Department Health for the NHS Health Checks Programme. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: KK MJD NS DW AG RG AM NV. Performed the experiments: MJD KK DW LJG AG RG AM NV. Analyzed the data: DHB LJG. Wrote the paper: DHB LJG JH DW AG RG AM NV NS MJD KK. Conceived the analyses: KK MJD NS. Designed the ADDITION-Leicester study: MJD KK DW. Designed the JHW study: AG RG. Designed the New Delhi study: AM NV. Conducted the ADDITION-Leicester study: MJD KK DW LJG. Conducted the JHW study: AG RG. Conducted the New Delhi study: AM NV. Combined the data from the three studies: DHB JH. Performed all statistical analyses: DHB. Supported performance of all statistical analyses: LJG. Wrote the first draft of the manuscript: DHB. Contributed to the interpretation of the results and drafting/revising the manuscript: DHB LJG JH DW AG AM RG NV NS MJD KK.